Status:
UNKNOWN
Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer
Lead Sponsor:
Nanjing Medical University
Conditions:
Cancer of Pancreas
Ossification, Heterotopic
Eligibility:
All Genders
18-80 years
Brief Summary
To investigate whether pancreatic cancer is the cause of heterotopic ossification of abdominal incision.
Detailed Description
Heterotopic ossification of abdominal incision (HOAI) has long been regarded as a rare complication after general surgery. However,according to our retrospective analysis. HOAI was more frequently obs...
Eligibility Criteria
Inclusion
- Obtain informed consent from the patients.
- The patient's abdominal incision was double-closed with continuous suture of linea alba and fascia with absorbable suture, and skin was sutured with skin staples.
Exclusion
- Refusing to join the study
- Previous history of malignant tumor
- Previous history of midabdominal incision
- Abnormal calcium and phosphorus metabolism
- Distant metastasis
- Palliative operation
- performing neoadjuvant chemotherapy
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04049461
Start Date
September 1 2019
End Date
December 31 2025
Last Update
August 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The first affiliated hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029